| RS786205675 |
HPCA
|
Health Risk |
Pathogenic |
Torsion dystonia 2, Torsion dystonia 2 |
| RS786205676 |
KDM6A
|
Health Risk |
Pathogenic |
Kabuki syndrome 2, Kabuki syndrome 2 |
| RS786205677 |
NHS
|
Health Risk |
Pathogenic |
Nance-Horan syndrome, Nance-Horan syndrome |
| RS786205679 |
AFF4
|
Health Risk |
Pathogenic/Likely pathogenic |
Cognitive impairment - coarse facies - heart defects - obesity - pulmonary involvement - short stature - skeletal dysplasia syndrome, Cognitive impairment - coarse facies - heart defects - obesity - pulmonary involvement - short stature - skeletal dysplasia syndrome |
| RS786205680 |
AFF4
|
Health Risk |
Pathogenic/Likely pathogenic |
Cognitive impairment - coarse facies - heart defects - obesity - pulmonary involvement - short stature - skeletal dysplasia syndrome, Cognitive impairment - coarse facies - heart defects - obesity - pulmonary involvement - short stature - skeletal dysplasia syndrome |
| RS786205688 |
POLK
|
Health Risk |
Pathogenic |
Prostate cancer, Prostate cancer |
| RS786205697 |
CENPF
|
Health Risk |
Pathogenic |
Stromme syndrome, Stromme syndrome |
| RS786205698 |
TTC7A
|
Health Risk |
Pathogenic |
Multiple gastrointestinal atresias, Gastrointestinal defects and immunodeficiency syndrome 1 |
| RS786205699 |
TXNL4A
|
Health Risk |
Pathogenic/Likely pathogenic |
Choanal atresia-hearing loss-cardiac defects-craniofacial dysmorphism syndrome, TXNL4A-related disorder |
| RS786205702 |
RTEL1
|
Health Risk |
Pathogenic/Likely risk allele |
Pulmonary fibrosis, Pulmonary fibrosis and/or bone marrow failure |
| RS786205703 |
DEPDC5
|
Health Risk |
Pathogenic |
Epilepsy, familial focal |
| RS786205704 |
JAGN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe congenital neutropenia, Autosomal recessive severe congenital neutropenia due to JAGN1 deficiency |
| RS786205705 |
JAGN1
|
Health Risk |
Pathogenic |
Severe congenital neutropenia, Severe congenital neutropenia |
| RS786205707 |
AKAP9
|
Health Risk |
Conflicting classifications of pathogenicity |
Ventricular fibrillation, Long QT syndrome |
| RS786205709 |
AKAP9
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiac arrhythmia |
| RS786205712 |
AKAP9
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS786205713 |
AKAP9
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS786205724 |
ANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
ANK2-related disorder, ANK2-related disorder |
| RS786205725 |
ANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Long QT syndrome |
| RS786205727 |
ANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congestive heart failure, Congestive heart failure |
| RS786205741 |
CACNA1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS786205742 |
CACNA1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Long QT syndrome |
| RS786205745 |
CACNA1C
|
Health Risk |
Pathogenic |
Timothy syndrome, Long QT syndrome |
| RS786205748 |
CACNA1C
|
Health Risk |
Likely pathogenic |
Long QT syndrome, Long QT syndrome 8 |
| RS786205753 |
CACNA1C
|
Health Risk |
Pathogenic/Likely pathogenic |
Long QT syndrome, Long QT syndrome 8 |
| RS786205755 |
CACNA1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Autism spectrum disorder |
| RS786205759 |
CACNA1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Long QT syndrome |
| RS786205771 |
CACNA1C
|
Health Risk |
Likely pathogenic |
Long QT syndrome, Cardiovascular phenotype |
| RS786205773 |
CACNA1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS786205776 |
CACNA1C
|
Health Risk |
Likely pathogenic |
Long QT syndrome, Long QT syndrome |
| RS786205779 |
CACNA1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS786205782 |
CACNA1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Timothy syndrome |
| RS786205791 |
CASQ2
|
Health Risk |
Pathogenic/Likely pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 2 |
| RS786205792 |
CASQ2
|
Health Risk |
Pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS786205795 |
CASQ2
|
Health Risk |
Pathogenic |
— |
| RS786205799 |
CASQ2
|
Health Risk |
Pathogenic/Likely pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 2 |
| RS786205811 |
KCNJ2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Short QT syndrome type 3 |
| RS786205812 |
KCNJ2
|
Health Risk |
Conflicting classifications of pathogenicity |
Short QT syndrome type 3, Andersen Tawil syndrome |
| RS786205817 |
KCNJ2
|
Health Risk |
Likely pathogenic |
Short QT syndrome type 3, Andersen Tawil syndrome |
| RS786205818 |
KCNJ2
|
Health Risk |
Conflicting classifications of pathogenicity |
Andersen Tawil syndrome, Short QT syndrome type 3 |
| RS786205820 |
KCNJ2
|
Health Risk |
Pathogenic/Likely pathogenic |
Andersen Tawil syndrome, Short QT syndrome type 3 |
| RS786205826 |
NKX2-5
|
Health Risk |
Pathogenic |
— |
| RS786205828 |
SCN1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome 5, Brugada syndrome 5 |
| RS786205829 |
SCN1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome 5, Brugada syndrome 5 |
| RS786205830 |
SCN1B
|
Health Risk |
Pathogenic/Likely pathogenic |
Generalized epilepsy with febrile seizures plus, type 1 |
| RS786205834 |
SCN1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome 5, Generalized epilepsy with febrile seizures plus |
| RS786205835 |
SCN1B
|
Health Risk |
Likely pathogenic |
Brugada syndrome 5, Brugada syndrome 5 |
| RS786205837 |
SCN1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome 5, Cardiovascular phenotype |
| RS786205841 |
SNTA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Long QT syndrome 12 |
| RS786205846 |
SNTA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Long QT syndrome |
| RS786205848 |
SNTA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Long QT syndrome 12 |
| RS786205852 |
CABP4
|
Health Risk |
Pathogenic |
Cone-rod synaptic disorder, congenital nonprogressive |
| RS786205853 |
GNAT1
|
Health Risk |
Pathogenic |
Congenital stationary night blindness autosomal dominant 3, Congenital stationary night blindness autosomal dominant 3 |
| RS786205854 |
GNAT1
|
Health Risk |
Pathogenic |
Congenital stationary night blindness 1G, Congenital stationary night blindness 1G |
| RS786205855 |
IFT172
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome 20, Retinitis pigmentosa 71 |
| RS786205856 |
IFT172
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 71, Retinitis pigmentosa 71 |
| RS786205857 |
IFT172
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 71, Retinitis pigmentosa 71 |
| RS786205858 |
IFT172
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 71, Retinitis pigmentosa 71 |
| RS786205859 |
TBL1XR1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 41 |
| RS786205860 |
KCTD17
|
Health Risk |
Pathogenic |
Myoclonic dystonia 26, Myoclonic dystonia 26 |
| RS786205861 |
GCDH
|
Health Risk |
Likely pathogenic |
Glutaric aciduria, type 1 |
| RS786205862 |
GCDH
|
Health Risk |
Pathogenic |
Glutaric aciduria, type 1 |
| RS786205864 |
STK11
|
Health Risk |
Pathogenic |
Peutz-Jeghers syndrome, Peutz-Jeghers syndrome |
| RS786205865 |
EEF1A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, autosomal dominant 38 |
| RS786205866 |
EEF1A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, autosomal dominant 38 |
| RS786205867 |
KCND3
|
Health Risk |
Pathogenic/Likely pathogenic |
Brugada syndrome 9, Spinocerebellar ataxia type 19/22 |
| RS786205868 |
TRPV3
|
Health Risk |
Pathogenic/Likely pathogenic |
Olmsted syndrome 1, Isolated focal non-epidermolytic palmoplantar keratoderma |
| RS786205869 |
TRPV3
|
Health Risk |
Pathogenic |
Isolated focal non-epidermolytic palmoplantar keratoderma, Isolated focal non-epidermolytic palmoplantar keratoderma |
| RS786205870 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Dystonia 27, Bethlem myopathy 1A |
| RS786205871 |
SUCLG1
|
Health Risk |
Pathogenic |
Mitochondrial DNA depletion syndrome 9, Mitochondrial DNA depletion syndrome 9 |
| RS786205872 |
PLOD3
|
Health Risk |
Pathogenic |
Bone fragility with contractures, arterial rupture |
| RS786205873 |
OTX2
|
Health Risk |
Pathogenic |
Syndromic microphthalmia type 5, Syndromic microphthalmia type 5 |
| RS786205874 |
OTX2
|
Health Risk |
Pathogenic |
Syndromic microphthalmia type 5, Syndromic microphthalmia type 5 |
| RS786205875 |
POR
|
Health Risk |
Pathogenic |
Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis, Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency |
| RS786205876 |
POR
|
Health Risk |
Likely pathogenic |
Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis, Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency |
| RS786205878 |
POR
|
Health Risk |
Pathogenic |
Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis, Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis |
| RS786205879 |
OTX2
|
Health Risk |
Pathogenic |
Syndromic microphthalmia type 5, Syndromic microphthalmia type 5 |
| RS786205880 |
OSBPL2
|
Health Risk |
Pathogenic |
Autosomal dominant nonsyndromic hearing loss 67, Autosomal dominant nonsyndromic hearing loss 67 |
| RS786205881 |
OSBPL2
|
Health Risk |
Pathogenic |
Autosomal dominant nonsyndromic hearing loss 67, Autosomal dominant nonsyndromic hearing loss 67 |
| RS786205882 |
PNPLA8
|
Health Risk |
Pathogenic |
Mitochondrial myopathy-lactic acidosis-deafness syndrome, Mitochondrial myopathy-lactic acidosis-deafness syndrome |
| RS786205883 |
SCARF2
|
Health Risk |
Pathogenic |
Van den Ende-Gupta syndrome, Van den Ende-Gupta syndrome |
| RS786205884 |
OTX2
|
Health Risk |
Pathogenic |
Syndromic microphthalmia type 5, Syndromic microphthalmia type 5 |
| RS786205885 |
RAPSN
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 11, Congenital myasthenic syndrome |
| RS786205887 |
WNT3
|
Health Risk |
Likely pathogenic |
Bladder exstrophy-epispadias-cloacal extrophy complex, Bladder exstrophy-epispadias-cloacal extrophy complex |
| RS786205890 |
ORAI1
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to ORAI1 deficiency, Combined immunodeficiency due to ORAI1 deficiency |
| RS786205892 |
MECP2
|
Health Risk |
Pathogenic |
Rett syndrome, Rett syndrome |
| RS786205895 |
MECP2
|
Health Risk |
Pathogenic |
Rett syndrome, Rett syndrome |
| RS786205896 |
FRMD7
|
Health Risk |
Pathogenic |
Nystagmus 1, congenital |
| RS786205897 |
COQ9
|
Health Risk |
Pathogenic |
Encephalopathy-hypertrophic cardiomyopathy-renal tubular disease syndrome, Encephalopathy-hypertrophic cardiomyopathy-renal tubular disease syndrome |
| RS786205899 |
GALNS
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-IV-A |
| RS786205900 |
KIF11
|
Health Risk |
Pathogenic |
Microcephaly with or without chorioretinopathy, lymphedema |
| RS786205901 |
XPR1
|
Health Risk |
Pathogenic |
Basal ganglia calcification, idiopathic |
| RS786205902 |
XPR1
|
Health Risk |
Pathogenic |
Basal ganglia calcification, idiopathic |
| RS786205903 |
XPR1
|
Health Risk |
Pathogenic |
Basal ganglia calcification, idiopathic |
| RS786205904 |
XPR1
|
Health Risk |
Pathogenic |
Basal ganglia calcification, idiopathic |
| RS786205905 |
MYH7
|
Health Risk |
Likely pathogenic |
Cardiomyopathy, Hypertrophic cardiomyopathy |
| RS786205909 |
CNNM2
|
Health Risk |
Pathogenic |
Hypomagnesemia, seizures |
| RS786205910 |
CNNM2
|
Health Risk |
Pathogenic |
Hypomagnesemia, seizures |
| RS78624439 |
PKHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS78627723 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2C, Usher syndrome type 2C |